Authors:
Davidson, B
Goldberg, I
Berner, A
Nesland, JM
Givant-Horwitz, V
Byrne, M
Risberg, B
Kristensen, GB
Trope, CG
Kopolovic, J
Reich, R
Citation: B. Davidson et al., Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions, AM J CLIN P, 115(4), 2001, pp. 517-524
Authors:
Davidson, B
Reich, R
Goldberg, I
Gotlieb, WH
Kopolovic, J
Berner, A
Ben-Baruch, G
Bryne, M
Nesland, JM
Citation: B. Davidson et al., Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma, CLIN CANC R, 7(3), 2001, pp. 551-557
Authors:
Davidson, B
Lazarovici, P
Ezersky, A
Nesland, JM
Berner, A
Risberg, B
Trope, CG
Kristensen, GB
Goscinski, M
van de Putte, G
Reich, R
Citation: B. Davidson et al., Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients, CLIN CANC R, 7(11), 2001, pp. 3457-3464
Authors:
Suo, ZH
Yang, HH
Mei, Q
Skovlund, E
Cui, JG
Nesland, JM
Citation: Zh. Suo et al., Type 1 protein tyrosine kinases in Chinese breast carcinomas - A clinicopathologic study, INT J SUR P, 9(3), 2001, pp. 177-187
Authors:
Peng, Q
Soler, AM
Warloe, T
Nesland, JM
Giercksky, KE
Citation: Q. Peng et al., Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate, J PHOTOCH B, 62(3), 2001, pp. 140-145
Authors:
Davidson, B
Reich, R
Berner, A
Givant-Horwitz, V
Goldberg, I
Risberg, B
Kristensen, GB
Trope, CG
Bryne, M
Kopolovic, J
Nesland, JM
Citation: B. Davidson et al., Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels, EUR J CANC, 37(16), 2001, pp. 2040-2049
Authors:
Forus, A
D'Angelo, A
Henriksen, J
Merla, G
Maelandsmo, GM
Florenes, VA
Olivieri, S
Bjerkehagen, B
Meza-Zepeda, LA
Blanco, FD
Muller, C
Sanvito, F
Kononen, J
Nesland, JM
Fodstad, O
Reymond, A
Kallioniemi, OP
Arrigoni, G
Ballabio, A
Myklebost, O
Zollo, M
Citation: A. Forus et al., Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas - a possible mechanism for altering the nm23-H1 activity, ONCOGENE, 20(47), 2001, pp. 6881-6890
Authors:
Luksiene, Z
Eggen, I
Moan, J
Nesland, JM
Peng, Q
Citation: Z. Luksiene et al., Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells, CANCER LETT, 169(1), 2001, pp. 33-39
Authors:
Davidson, B
Goldberg, I
Kopolovic, J
Gotlieb, WH
Givant-Horwitz, V
Nesland, JM
Berner, A
Ben-Baruch, G
Bryne, M
Reich, R
Citation: B. Davidson et al., Expression of angiogenesis-related genes in ovarian carcinoma - A clinicopathologic study, CLIN EXP M, 18(6), 2001, pp. 501-507
Authors:
Borgen, E
Naume, B
Nesland, JM
Nowels, KW
Pavlak, N
Ravkin, I
Goldbard, S
Citation: E. Borgen et al., Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples, CYTOMETRY, 46(4), 2001, pp. 215-221
Authors:
Suo, ZH
Bjaamer, A
Ottestad, L
Nesland, JM
Citation: Zh. Suo et al., Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast, ULTRA PATH, 25(5), 2001, pp. 349-356
Authors:
Davidson, B
Risberg, B
Goldberg, I
Nesland, JM
Berner, A
Trope, CG
Kristensen, GB
Bryne, M
Reich, R
Citation: B. Davidson et al., Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients isa marker of poor outcome, AM J SURG P, 25(12), 2001, pp. 1493-1500
Authors:
Davidson, B
Risberg, B
Berner, A
Nesland, JM
Trope, CG
Kristensen, GB
Bryne, M
Goscinski, M
de Putte, GV
Florenes, VA
Citation: B. Davidson et al., Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications, GYNECOL ONC, 83(2), 2001, pp. 249-256
Authors:
Davidson, B
Nesland, JM
Goldberg, I
Kopolovic, J
Gotlieb, WH
Byrne, M
Ben-Baruch, G
Berner, A
Reich, R
Citation: B. Davidson et al., Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathologic study, GYNECOL ONC, 81(2), 2001, pp. 166-171
Authors:
Thorstensen, L
Qvist, H
Nesland, JM
Giercksky, KE
Lothe, RA
Citation: L. Thorstensen et al., Identification of two potential suppressor gene regions on chromosome arm 14q that are commonly lost in advanced colorectal carcinomas, SC J GASTR, 36(12), 2001, pp. 1327-1331
Authors:
Saeterdal, I
Bjorheim, J
Lislerud, K
Gjertsen, MK
Bukholm, IK
Olsen, OC
Nesland, JM
Eriksen, JA
Moller, M
Lindblom, A
Gaudernack, G
Citation: I. Saeterdal et al., Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer, P NAS US, 98(23), 2001, pp. 13255-13260
Authors:
Florenes, VA
Maelandsmo, GM
Faye, R
Nesland, JM
Holm, R
Citation: Va. Florenes et al., Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome, J PATHOLOGY, 195(5), 2001, pp. 530-536
Citation: Irk. Bukholm et al., Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas, INT J CANC, 93(2), 2001, pp. 283-287
Authors:
Peng, Q
Warloe, T
Moan, J
Godal, A
Apricena, F
Giercksky, KE
Nesland, JM
Citation: Q. Peng et al., Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts, CANCER RES, 61(15), 2001, pp. 5824-5832
Authors:
Thorstensen, L
Qvist, H
Heim, S
Liefers, GJ
Nesland, JM
Giercksky, KE
Lothe, RA
Citation: L. Thorstensen et al., Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients, NEOPLASIA, 2(6), 2000, pp. 514-522
Authors:
Anvar, MD
Khiabani, HZ
Nesland, JM
Stranden, E
Kroese, AJ
Citation: Md. Anvar et al., Vascular and stromal features in the skin of the lower limb in patients with chronic critical limb ischaemia (CLI) and oedema, EUR J VAS E, 20(2), 2000, pp. 125-131
Authors:
Florenes, VA
Faye, RS
Maelandsmo, GM
Nesland, JM
Holm, R
Citation: Va. Florenes et al., Levels of cyclin D1 and D3 in malignant melanoma: Deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma, CLIN CANC R, 6(9), 2000, pp. 3614-3620